We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan · Delayed Price · Currency is TWD 23.35
+0.95 (4.24%)
Aug 20, 2026, 11:13 AM CST
We Can Medicines Market Cap
We Can Medicines has a market cap or net worth of 1.05 billion as of August 20, 2026. Its market cap has decreased by -27.66% in one year.
Market Cap
1.05B
Enterprise Value
1.94B
Revenue
3.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
23.35
ChartMarket Cap Chart
Since December 9, 2022, We Can Medicines's market cap has decreased from 1.84B to 1.05B, a decrease of -42.79%. That is a compound annual growth rate of -14.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 1.05B | -31.98% |
| Dec 31, 2025 | 1.55B | -10.72% |
| Dec 31, 2024 | 1.73B | -59.87% |
| Dec 29, 2023 | 4.32B | 13.80% |
| Dec 30, 2022 | 3.80B | 106.30% |
| Dec 9, 2022 | 1.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eagle Cold Storage Enterprise | 4.02B |
| Fwusow Industry | 3.82B |
| SunWay Biotech Co., LTD. | 3.56B |
| Ten Ren Tea | 2.53B |
| Wonder Pets Enterprises | 2.17B |
| Hantech Bio-Technology | 2.10B |
| Tai Roun Products | 1.92B |
| Far East Bio-Tec | 1.49B |